Fulvia Ceccarelli: Efficacy of Anifrolumab in Lupus-Associated Autoimmune Haemolytic Anaemia
Fulvia Ceccarelli, Associate Professor of Rheumatology at Sapienza University of Rome, shared a post on LinkedIn about a recent article she and her colleagues co-authores, published in Lupus Science and Medicine, adding:
“We are proud to share our last contribution on efficacy of anifrolumab on lupus autoimmune haemolytic anaemia.
The study is the result of a spontaneous and friendly collaboration among centers in various Italian region.”
Title: Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab
Authors: Fulvia Ceccarelli, Rossella De Angelis, Francesca Bottazzi, Danila Madonna, Melania Alessia Coscia, Noemi Italiano, Emanuela Praino, Emanuela Sabatini, Leonardo Santo, Lorenzo Cavagna, Fabrizio Conti
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:42Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:53Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
-
Jul 29, 2026, 14:46François Saller: TFPI-Targeting VHHs for Haemophilia and Rare Bleeding Disorders